VCAN and acute myeloid leukemia: The results showed that a higher VCAN gene expression predicted shorter overall survival in AML cases compared to a lower VCAN gene expression (median, 12.17 vs 26.40 months; p = 0.0247, Figure 6A), and high VCAN expression had a 1.1 - 2.4 fold higher hazard ratio (HR).